No Data
No Data
Why Investors Were Avoiding GeneDx Holdings Stock This Week
Jefferies Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $80
Analysts Have Conflicting Sentiments on These Healthcare Companies: GeneDx Holdings (WGS) and Dexcom (DXCM)
TD Cowen Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $110
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Cuts Target Price to $100
GeneDx Holdings Price Target Cut to $110.00/Share From $135.00 by TD Securities